Atlas Trials

A Repeat Dose Positron Emission Tomography Study With GSK1144814

Clinical trial NCT01209039 · COMPLETED

Trial details

NCT number
NCT01209039
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-07-01
Primary completion
2009-10-25
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.